ITSN2
Basic information
Region (hg38): 2:24202864-24360536
Previous symbols: [ "SH3D1B" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (194 variants)
- not_provided (143 variants)
- ITSN2-related_disorder (76 variants)
- Landau-Kleffner_syndrome (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ITSN2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000006277.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 42 | 51 | ||||
missense | 240 | 15 | 261 | |||
nonsense | 1 | |||||
start loss | 2 | 2 | ||||
frameshift | 2 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
Total | 0 | 0 | 250 | 58 | 13 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ITSN2 | protein_coding | protein_coding | ENST00000355123 | 39 | 157851 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.75e-13 | 1.00 | 125599 | 1 | 148 | 125748 | 0.000593 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.12 | 788 | 881 | 0.894 | 0.0000479 | 11073 |
Missense in Polyphen | 90 | 135.5 | 0.66421 | 1656 | ||
Synonymous | -0.603 | 333 | 319 | 1.04 | 0.0000168 | 3129 |
Loss of Function | 6.00 | 41 | 108 | 0.378 | 0.00000587 | 1276 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00136 | 0.00135 |
Ashkenazi Jewish | 0.000419 | 0.000397 |
East Asian | 0.000551 | 0.000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000649 | 0.000633 |
Middle Eastern | 0.000551 | 0.000544 |
South Asian | 0.000741 | 0.000719 |
Other | 0.000491 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Adapter protein that may provide indirect link between the endocytic membrane traffic and the actin assembly machinery. May regulate the formation of clathrin-coated vesicles (CCPs). Seems to be involved in CCPs maturation including invagination or budding. Involved in endocytosis of integrin beta-1 (ITGB1) and transferrin receptor (TFR). Plays a role in dendrite formation by melanocytes (PubMed:23999003). {ECO:0000269|PubMed:19458185, ECO:0000269|PubMed:22648170, ECO:0000269|PubMed:23999003}.;
- Pathway
- Vesicle-mediated transport;Membrane Trafficking;TCR;Clathrin-mediated endocytosis;EGFR1;Cargo recognition for clathrin-mediated endocytosis;Regulation of CDC42 activity
(Consensus)
Recessive Scores
- pRec
- 0.183
Intolerance Scores
- loftool
- 0.926
- rvis_EVS
- -0.51
- rvis_percentile_EVS
- 21.42
Haploinsufficiency Scores
- pHI
- 0.301
- hipred
- N
- hipred_score
- 0.476
- ghis
- 0.547
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.634
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | Medium | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Itsn2
- Phenotype
- homeostasis/metabolism phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype;
Gene ontology
- Biological process
- endocytosis;positive regulation of signal transduction;viral process;regulation of Rho protein signal transduction;positive regulation of dendrite extension
- Cellular component
- cytoplasm;centrosome;extracellular exosome
- Molecular function
- SH3/SH2 adaptor activity;Rho guanyl-nucleotide exchange factor activity;calcium ion binding;protein binding